Cargando…
Tacrolimus‐induced hypomagnesemia and hypercalciuria requires FKBP12 suggesting a role for calcineurin
Calcineurin inhibitors (CNIs) are immunosuppressive drugs used to prevent graft rejection after organ transplant. Common side effects include renal magnesium wasting and hypomagnesemia, which may contribute to new‐onset diabetes mellitus, and hypercalciuria, which may contribute to post‐transplant o...
Autores principales: | Gratreak, Brittany D. K., Swanson, Elizabeth A., Lazelle, Rebecca A., Jelen, Sabina K., Hoenderop, Joost, Bindels, René J., Yang, Chao‐Ling, Ellison, David H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944708/ https://www.ncbi.nlm.nih.gov/pubmed/31908154 http://dx.doi.org/10.14814/phy2.14316 |
Ejemplares similares
-
Familial Hypomagnesemia, Hypercalciuria and Nephrocalcinosis with Novel Mutation
por: Margabandhu, S., et al.
Publicado: (2019) -
An Uncommon Cause of Hypomagnesemia With Hypercalciuria and Nephrocalcinosis in a Young Woman
por: Rudovich, Natalia N, et al.
Publicado: (2021) -
Diabetes-induced hypomagnesemia is not modulated by metformin treatment in mice
por: Kurstjens, Steef, et al.
Publicado: (2019) -
Claudin-19 Mutations and Clinical Phenotype in Spanish Patients with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis
por: Claverie-Martín, Félix, et al.
Publicado: (2013) -
Correction: Claudin-19 Mutations and Clinical Phenotype in Spanish Patients with Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis
por: Claverie-Martín, Félix, et al.
Publicado: (2013)